Mahmoud F. Abo-Ashour
Research Subjects
Mahmoud F. Abo-Ashour has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Wagdy Mohamed Eldehna
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, Kafr El Sheikh 33516, Egypt
10 shared publications - Claudiu Trandafir Supuran
Department of NEUROFARBA, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Polo Scientifico, Via U. Schiff 6, Sesto Fiorentino, Firenze, 50019, Italy
7 shared publications - Alessio Nocentini
University of Florence
6 shared publications - Hatem A. Abdel-Aziz
Department of Applied Organic Chemistry, National Research Center, Dokki, Cairo 12622, Egypt
5 shared publications - Mahmoud M. Elaasser
Al-Azhar University
5 shared publications - Hany S. Ibrahim
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Egyptian Russian University, Badr City, Cairo 11829, Egypt; Department of Medicinal Chemistry, Institute of Pharmacy, Martin-Luther-University of Halle-Wittenberg, 06120 Halle (Saale), Germany
4 shared publications
Latest Publications
- 1 October 2019
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 179, 547-556
Application of hydrazino and hydrazido linkers to connect benzenesulfonamides with hydrophilic/phobic tails for targeting the middle region of human carbonic anhydrases active site: Selective inhibitors of hCA IX
- 1 October 2019
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 179, 547-556
Application of hydrazino and hydrazido linkers to connect benzenesulfonamides with hydrophilic/phobic tails for targeting the middle region of human carbonic anhydrases active site: Selective inhibitors of hCA IX
- 1 January 2019
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 162, 147-160
Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: Design and synthesis of novel N-substituted isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and antitumor agents
- 1 January 2019
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 162, 147-160
Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: Design and synthesis of novel N-substituted isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and antitumor agents
- 1 December 2018
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 160, 49-60
Novel indole-thiazolidinone conjugates: Design, synthesis and whole-cell phenotypic evaluation as a novel class of antimicrobial agents
- 1 December 2018
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 160, 49-60
Novel indole-thiazolidinone conjugates: Design, synthesis and whole-cell phenotypic evaluation as a novel class of antimicrobial agents
- 1 September 2018
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 157, 28-36
Novel hydrazido benzenesulfonamides-isatin conjugates: Synthesis, carbonic anhydrase inhibitory activity and molecular modeling studies
- 1 September 2018
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 157, 28-36
Novel hydrazido benzenesulfonamides-isatin conjugates: Synthesis, carbonic anhydrase inhibitory activity and molecular modeling studies
- 23 May 2018
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 10 (12) , 1405-1419
Synthesis and Biological Evaluation of 2-Aminothiazole-Thiazolidinone Conjugates as Potential Antitubercular Agents
Aim: Mycobacterium tuberculosis, which causes tuberculosis, continues to infect millions of the global population, resulting in 1.8 million deaths worldwide in 2015. Methodology: Hybrids of 2-amino-4-methylthiazole bearing 5-acetyl/5-ethyl carboxylate functionality with 5-arylidene thiazolidinone moiety (6a–k and 9a–d) were synthesized and screened for antitubercular and antimicrobial activities. Results & discussion: 5-ethyl carboxylate derivative 6k revealed half antitubercular activity (minimal inhibitory concentration = 1.56 μg/ml) than the acetyl analog 6c (minimal inhibitory concentration = 0.78 μg/ml), however, it exhibited more potent broad spectrum antibacterial and antifungal activities in addition to its excellent safety profile with high selectivity toward M. tuberculosis over normal human lung cells. Collectively, these data suggested that compound 6k can be considered as an ideal lead compound for further optimization. Graphical abstract
- 23 May 2018
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 10 (12) , 1405-1419
Synthesis and Biological Evaluation of 2-Aminothiazole-Thiazolidinone Conjugates as Potential Antitubercular Agents
Aim: Mycobacterium tuberculosis, which causes tuberculosis, continues to infect millions of the global population, resulting in 1.8 million deaths worldwide in 2015. Methodology: Hybrids of 2-amino-4-methylthiazole bearing 5-acetyl/5-ethyl carboxylate functionality with 5-arylidene thiazolidinone moiety (6a–k and 9a–d) were synthesized and screened for antitubercular and antimicrobial activities. Results & discussion: 5-ethyl carboxylate derivative 6k revealed half antitubercular activity (minimal inhibitory concentration = 1.56 μg/ml) than the acetyl analog 6c (minimal inhibitory concentration = 0.78 μg/ml), however, it exhibited more potent broad spectrum antibacterial and antifungal activities in addition to its excellent safety profile with high selectivity toward M. tuberculosis over normal human lung cells. Collectively, these data suggested that compound 6k can be considered as an ideal lead compound for further optimization. Graphical abstract